Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

IL-31: A new link between T cells and pruritus in atopic skin inflammation

Enikö Sonkoly, Anja Müller, Antti Lauerma et al. · Journal of Allergy and Clinical Immunology · 2006 · 990 citations

Medicine, Dermatology, Immunology +16

A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1

Ferda Cevikbas, Xidao Wang, Tasuku Akiyama et al. · Journal of Allergy and Clinical Immunology · 2013 · 768 citations · Full text

Life Sciences, Immunology, Physiology +12

Patient burden and quality of life in atopic dermatitis in US adults

Jonathan I. Silverberg, Joel M. Gelfand, David J. Margolis et al. · Annals of Allergy Asthma & Immunology · 2018 · 625 citations · Full text

Medicine, Dermatology, Allergy +16

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue et al. · New England Journal of Medicine · 2017 · 587 citations · Full text

Medicine, Dermatology, Immunology +15

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 453 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16